Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Aura Biosciences raises $80m for VDC therapies for cancers Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round… bySrinathMarch 22, 2021
